Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.

Meng Li, Marie Woelfer, Lejla Colic, Adam Safron, Catie Chang, Hans-Jochen Heinze, Oliver Speck, Helen S Mayberg, Bharat B Biswal, Giacomo Salvadore, Anna Fejtova, Martin Walter

Journal: European archives of psychiatry and clinical neuroscience 2020;270(2):207-216

PMID: 30353262

Abstract

Ketamine exerts rapid antidepressant effects peaking 24 h after a single infusion, which have been suggested to be reflected by both reduced functional connectivity (FC) within default mode network (DMN) and altered glutamatergic levels in the perigenual anterior cingulate cortex (pgACC) at 24 h. Understanding the interrelation and time point specificity of ketamine-induced changes of brain circuitry and metabolism is thus key to future therapeutic developments. We investigated the correlation of late glutamatergic changes with FC changes seeded from the posterior cingulate cortex (PCC) and tested the prediction of the latter by acute fractional amplitude of low-frequency fluctuations (fALFF). In a double-blind, randomized, placebo-controlled study of 61 healthy subjects, we compared effects of subanesthetic ketamine infusion (0.5 mg/kg over 40 min) on resting-state fMRI and MR-Spectroscopy at 7 T 1 h and 24 h post-infusion. FC decrease between PCC and dorsomedial prefrontal cortex (dmPFC) was found at 24 h post-infusion (but not 1 h) and this FC decrease correlated with glutamatergic changes at 24 h in pgACC. Acute increase in fALFF was found in ventral PCC at 1 h which was not observed at 24 h and inversely correlated with the reduced dPCC FC towards the dmPFC at 24 h. The correlation of metabolic and functional markers of delayed ketamine effects and their temporal specificity suggest a potential mechanistic relationship between glutamatergic modulation and reconfiguration of brain regions belonging to the DMN.

Address: Clinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany.; Otto-von-Guericke-University, Magdeburg, Germany.; New Jersey Institute of Technology, Newark, NJ, USA.; Department of Psychology, Northwestern University, Evanston, IL, USA.; Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA.; Department of Neurology, Otto-von-Guericke-University, Magdeburg, Germany.; Department Behavioral Neurology, Leibniz Institute for Neurobiology, Magdeburg, Germany.; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.; Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University, Magdeburg, Germany.; Department of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Janssen Research and Development, Titusville, NJ, USA.; Department of Psychiatry and Psychotherapy, University Hospital, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; RG Presynaptic Plasticity, Leibniz Institute for Neurobiology, Magdeburg, Germany.; Clinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany. [email protected].; Otto-von-Guericke-University, Magdeburg, Germany. [email protected].; Department Behavioral Neurology, Leibniz Institute for Neurobiology, Magdeburg, Germany. [email protected].; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany. [email protected].; Department of Psychiatry and Psychotherapy, University of Tuebingen, Osianderstrasse 24, 72076, Tuebingen, Germany. [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.